Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Life (Basel, Switzerland)|August 6, 2021
Small Molecules of Natural Origin as Potential Anti-HIV Agents: A Computational ApproachLuminita Crisan, Alina BoraScientific Reports|April 19, 2026
Harnessing machine learning models to repurpose drugs targeting HIV-1 integrase, protease, and reverse transcriptaseCiprian-Bogdan Chirila, Luminita CrisanInternational Journal of Molecular Sciences|June 10, 2023
New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico MethodsLiliana Pacureanu, Alina Bora, Luminita CrisanJournal of Biomolecular Structure & Dynamics|March 29, 2020
Comprehensive investigation of selectivity landscape of glycogen synthase kinase-3 inhibitorsLiliana Pacureanu, Sorin Avram, Luminita CrisanMolecular Diversity|January 22, 2017
Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitorsLuminita Crisan, Sorin Avram, Liliana PacureanuMolecules (Basel, Switzerland)|June 24, 2022
Homology Modeling and Molecular Docking Approaches for the Proposal of Novel Insecticides against the African Malaria Mosquito (Anopheles gambiae)Luminita Crisan, Simona Funar-Timofei, Ana BorotaMolecular Diversity|March 17, 2017
Combined molecular docking and QSAR study of fused heterocyclic herbicide inhibitors of D1 protein in photosystem II of plantsSimona Funar-Timofei, Ana Borota, Luminita CrisanMolecular Informatics|January 17, 2020
Partial Least Squares Discriminant Analysis and 3D Similarity Perspective Applied to Analyze Comprehensively the Selectivity of Glycogen Synthase Kinase 3 InhibitorsLuminita Crisan, Sorin Avram, Ludovic Kurunczi, et al.International Journal of Molecular Sciences|September 13, 2025
A Comprehensive Environmental and Molecular Strategy for the Evaluation of Fluroxypyr and Nature-Derived CompoundsIon Valeriu Caraba, Luminita Crisan, Marioara Nicoleta CarabaMolecular Diversity|November 25, 2020
Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson's disease treatmentLuminita Crisan, Daniela Istrate, Alina Bora, et al.Pageof 3